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Introduction
Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant disorders with a population frequency of 1 in 3500. ' The disease is clinically characterised by multiple neurofibromas, café-aulait spots and Lisch nodules of the iris. The NF1 gene, a tumour suppressor gene, resides on the proximal long arm of chromosome 17 (17qll.2) . It spans approximately 350 kb of genomic DNA and, comprising 60 exons, encodes the protein neurofibromin. 2 This protein, consisting of 2818 amino acids, contains a central domain that has homology with GTPase activating proteins (GAPs). 3 A distinct feature of the NF1 gene is the very high spontaneous mutation rate (1 x lCh 4 per gamete per generation), which is about 100-fold higher than the usual mutation rate for a single locus.' Up to 50% of all NF1 cases is supposed to result from de novo mutations. The NF1 gene provides a large target for mutations because of its relatively large size, but this may only account for a factor of 10 in terms of increase in mutation rate. 4 The presence of numerous NF1 pseudogenes has been proposed as an explanation for the high mutation rate in NF1. 5 In the human genome, at least 12 different NF1-related sequences have been identified on chromosomes 2, 12, 14, 15, 18, 21 and 22. 5 - 13 Most of the NF1 pseudogenes have been mapped in pericentromeric regions. The chromosome 2 NF1 pseudogene has been localised in region 2q21, which is known to contain the remnant of an ancestral centromere.
14 Due to the absence of selective pressure, mutations may accumulate in the NF1 pseudogenes. Consequently, the pseudogenes could act as reservoirs of mutations, which might be crossed into the functional NF1 gene by interchromosomal gene conversion. 5 Gene conversion, the non-reciprocal transfer of genetic information between two related sequences, has been recognised as a mutational mechanism for several human genes. 15 -' 7 In all these cases, the conversions occurred between gene and pseudogene on the same chromosome. For NF1, interchromosomal gene conversion is required, since none of the NF1 pseudogenes is located on chromosome 17. Interchromosomal gene conversion has been reported to occur between the von Willebrand factor gene on chromosome 12 and the von Willebrand pseudogene on chromosome 22.' 8 Gene conversion requires close contact between the functional gene and the corresponding pseudogene. The pericentromeric location of the functional NF1 gene and its pseudogenes might enable this close contact since centromeres tend to associate with each other in a non-random fashion.
, 9 -20 This is underlined by our finding that the NF1 pseudogenes on chromosomes 2, 14 and 22 have arisen by repeated transposition events between (peri)centromeric locations on these chromosomes. 13 As a matter of fact, the high mutation rate in NF1 cannot be explained exclusively by interchromosomal gene conversion. Only a small part of the functional NF1 gene is represented in the NF1 pseudogenes (see below), while NF1 gene mutations are scattered over the entire gene. In this study, however, we investigated whether in the overlapping part interchromosomal gene conversion contributes to the mutation rate in NF1.
Methods
Disease-causing NF1 mutations were taken from our own data and the literature. NF1 pseudogene sequences were obtained from our own data and publicly accessible databases. Yet unidentified NF1 pseudogene sequences, present in the first draft sequence of the human genome, were detected by performing a BLAST search using 
Results and Discussion
To test the hypothesis of interchromosomal gene conversion for NF1, we first inventoried all available NF1 pseudogene sequences (Table  1) . These include not only the published NF1 pseudogene sequences, but also thus far unidentified NF1 pseudogene sequences present in the first draft sequence of the human genome. In a previous study, we elucidated the complete nucleotide sequence of the NF1 pseudogene on chromosome 22.' 3 13 The BLAST search yielded two clones each containing an additional pseudogene variant on chromosome 14. In one of them, sequences corresponding to exons 10b, 12a -19a and 27b are present, while in the other only exons 12b -19a and 27b are represented. The chromosome 2 NF1 pseudogene was also found among the results from the BLAST search. In the NF1 pseudogene present in this particular clone, exons 12b -19a and 27b are represented.
The complete sequence of the chromosome 21 NF1 pseudogene has been determined. 7 In this pseudogene, exons 7-9 and 11 are represented. For chromosome 15, three different NF1 pseudogenes have been reported.6.11,12 A fourth locus might be present on chromosome 15, but this could not be substantiated." The representation of the chromosome 15 NF1 pseudogenes starts in intron 12b and ends in intron 27b. These pseudogenes are the only NF1 pseudogenes, known so far, with a nearly complete representation of the GAP-related domain, which is encoded by exons 20 -27a. Three chromosome 15 clones were found as a result from the BLAST search. One of them only contains sequences corresponding to exons 24 -27b, whereas in both the other two clones exons 13 -23-1 and 24 -27b are represented. The latter two clones contain the same NF1 pseudogene variant, but differ from the NF1 pseudogene present in the first. The BLAST search also yielded two unmapped clones, in which exons 13 -23-1 and 24 -27b are represented. The NF1 pseudogene present in one of these unmapped clones is, with the exception of two nucleotides, identical to the NF1 pseudogene variant present in the two clones that have been mapped to chromosome 15. Considering this and the fact that in l2 of which only exon 16 has been partially sequenced. 8 One of the NF1 pseudogenes that resulted from the BLAST search contains sequences corresponding to exons 16 and 17. The clone containing this pseudogene was derived from chromosome 6. However, alignments of exon 16 of this pseudogene to other NF1 pseudogenes showed a difference of only one nucleotide with the exon 16 sequence of the chromosome 12 NF1 pseudogene. Since no indications for a chromosome 6 NF1 pseudogene exist so far, we suppose this NF /-related sequence to originate from chromosome 12 rather than from chromosome 6. The NF1 pseudogene on chromosome 18 consists at the most of exons 7 -13. 12 Sequences of exons 8 and 9 have been reported. 8 The BLAST search yielded an NF1 pseudogene, mapped to chromosome 18p 11.2, in which exons 7-9 and 11 are represented. An overview of the exons represented in the various NF1 pseudogenes is given in Figure 1 , whereas all accessible NF1 pseudogene sequences are listed in Table 1 . When compared to the functional NF1 gene, substitutions, deletions and insertions are present in all NF I -related sequences.
We continued by collecting all point mutations and/or minor lesions in the NFI gene. In total, we found 225 different diseasecausing mutations in exons 7-9, 10b, 1 1 -23-1 and 24 -27b of the functional gene, the four regions known to be represented in the pseudogenes. These mutations included 30 novel disease-causing mutations that were taken from our own data (Fahsold et al., unpublished data; Nürnberg et al., unpublished data) . Only a very limited number (13 of 225, i.e. 5.8%) of these disease-causing mutations appears to have a pseudogene equivalent ( Table 2 ). In every pseudogene involved, we detected within a short distance, ranging from 2 to 25 nucleotides, from the disease-causing mutation at least one extra mutation compared with the functional NFI gene (Table 2) . If the 13 mutations would have been generated by interchromosomal gene conversion, it is likely that these extra mutations also would have been transposed into the functional gene of the NFI patients. However, none of them has been identified in the NFI gene of these NFI patients. Of the 13 mutations found, 6 reside in CpG sites resulting in C-to-T transitions. About 32% of all single basepair substitutions causing human genetic disease occur in CpG dinucleotides. 21 As CpGs of the NF1 coding region are subject to methylation, 22 these 6 C-to-T transitions are probably the result of spontaneous deamination of 5-methylcytosine rather than of interchromosomal gene conversion. This susceptibility for C-to-T transitions is substantiated by the fact that the 6 mutations found in both the functional gene and pseudogenes include 4 recurrent mutations of the NF1 gene (indicated in Table 2 ). Taken together, these results imply that the contribution of interchromosomal gene conversion to the high mutation rate in NF1 is, at best, limited.
